Dr. Riyue Bao's lab at the University of Pittsburgh focuses on understanding how certain tumors evade immune therapy, particularly in head and neck cancer. By investigating the role of a specific molecular target, p38 MAPK, the lab aims to improve cancer treatments. Using advanced techniques and large patient data sets, the research seeks to establish new therapeutic strategies that could help re-engage the immune system against tumors.

David W Schmidtke's research lab at the University of Texas Dallas focuses on understanding how the immune system behaves in patients with ventricular assist devices (VADs) who are at risk for infections. They aim to identify biomarkers that predict infections and develop innovative tools to assess immune function in these patients. The lab's goal is to improve patient outcomes by exploring new therapies that can enhance the immune response and reduce infection rates in individuals with heart failure.

Dr. Mariana Lazar's lab at NYU School of Medicine focuses on understanding how iron deficits may contribute to cognitive and psychological symptoms in individuals with Psychotic Spectrum Disorders. By using advanced imaging techniques, the lab seeks to explore the relationship between brain iron levels and mental health outcomes, ultimately aiming to develop new treatment strategies for these conditions.

Dr. Lawrence R. Frank's lab focuses on improving brain imaging techniques to study Alzheimer's Disease and related dementias. They have developed a new method called Joint Estimation Diffusion Imaging (JEDI) which enhances the ability to visualize subtle changes in brain tissue affected by Alzheimer’s. The ultimate goal is to create a tool that accurately detects and characterizes these changes to understand the disease better and possibly identify new treatments.

Dr. Thomas Link's lab at UCSF focuses on understanding how changes in body weight influence the progression of knee osteoarthritis (OA), particularly in overweight and obese individuals. The research aims to uncover the biological mechanisms behind this relationship, such as inflammation and muscle health, to develop personalized treatment strategies. By analyzing large datasets and utilizing advanced machine learning techniques, the lab hopes to create prediction models that can tailor interventions to patients, ultimately improving outcomes and preventing severe joint issues.

Dr. Michael John Evans' lab focuses on developing new radiotherapy strategies to treat prostate cancer by utilizing the unique biochemistry of human kallikrein 2 (hK2). The lab is pioneering novel low molecular weight peptides that can target cancer cells more effectively and safely, offering enhanced therapeutic benefits over current treatments. This research aims not only to improve tumor imaging and assessment but also to create targeted radiopharmaceuticals that can better deliver radiation directly to cancer cells while minimizing side effects.

Dr. Marites Pasuelo Melancon's research focuses on improving treatments for liver cancer patients by developing innovative drug delivery systems. Her lab aims to enhance liver regeneration before surgeries by creating degradable scaffolds that release a bile acid called obeticholic acid (OCA). This approach not only aids in the growth of healthy liver tissue but also reduces the risks of complications after surgery. Ultimately, her work could help more patients qualify for lifesaving liver surgeries.

Dr. Pawel K. Mazur’s lab focuses on understanding the roles of specific enzymes in lung cancer progression and treatment. The research investigates the regulation of lung squamous cell carcinoma and small cell lung cancer through the study of epigenetic factors such as NSD3, CARM1, and NSD2. By utilizing advanced mouse models and pharmacological approaches, the lab aims to uncover new therapeutic targets to improve cancer treatments and outcomes for patients.

Dr. Sina Tavakoli's lab focuses on improving the diagnosis and treatment of lung diseases, especially those related to inflammation and fibrosis. The lab is exploring innovative imaging techniques to assess immune responses in the lungs, particularly looking at a specific protein (CMKLR1) that is crucial in these diseases. By developing new molecular imaging tools, the lab aims to offer better precision in tracking disease progression and responses to treatments, ultimately enhancing patient care.

Nathaniel Huebsch's laboratory at Washington University focuses on combining advanced computational methods and smart materials to create innovative systems that simulate how mechanical forces affect tissues. By integrating real-time monitoring and control of tissue environments, the lab aims to improve drug screening processes and enhance the understanding of mechanobiology. This work has the potential to significantly impact how drug effects are studied, making them more applicable to real-life clinical scenarios.

Dr. Christos Constantinidis' lab studies the brain mechanisms that support visual working memory and how these functions can be improved in cases of mental illness or neurological conditions. The research primarily involves training monkeys on cognitive tasks while recording brain activity to understand how visual information is maintained and processed. By exploring the effects of stimulation of the Nucleus Basalis of Meynert on neural function, the lab aims to develop better treatments for cognitive impairments related to aging, injury, or mental health disorders.

Dr. Aaron Paul Batista's lab at the University of Pittsburgh focuses on understanding how the brain controls movement and how memories related to motor skills are formed and stored. By using brain-computer interfaces, the lab investigates the dynamics of neural population activity during tasks involving memory and movement, with the goal of developing new therapeutic strategies for stroke recovery and cognitive enhancement. Their research aims to provide better treatment options for neurological disorders through innovative tools that adjust neural patterns in real-time.

Dr. Yong Chen's lab focuses on improving cancer diagnosis and treatment monitoring using advanced MRI techniques, specifically Magnetic Resonance Fingerprinting (MRF). The lab aims to develop non-invasive methods for predicting treatment responses in breast cancer and characterizing renal cell carcinoma. By utilizing innovative imaging biomarkers, the research seeks to personalize and enhance patient care while reducing unnecessary procedures and associated healthcare costs.

The research lab led by Sudipto Dolui at the University of Pennsylvania focuses on improving the quality and reliability of magnetic resonance imaging (MRI) techniques, particularly for studying Alzheimer's disease and related dementias. They aim to develop automated methods for assessing the quality of cerebral blood flow images and harmonizing data collected from different MRI machines. By addressing variability in images from various sources, their work seeks to enhance research accuracy and lead to better diagnostics in aging-related conditions.

Dr. Zheng-Rong Lu's lab focuses on creating advanced anticancer therapies specifically targeting pancreatic cancer. The team is developing innovative nanovaccines made from lipid nanoparticles that aim to enhance immunotherapy effectiveness against this aggressive cancer. By combining these nanovaccines with immune checkpoint inhibitors, the research seeks to significantly improve treatment outcomes for patients with pancreatic ductal adenocarcinoma, a disease known for its low survival rates.

Dr. Jiangyang Zhang's lab at NYU School of Medicine focuses on understanding and developing treatments for neonatal hypoxic ischemic injury, a serious condition affecting infants. They use advanced imaging techniques to study how this injury affects brain tissue and to evaluate the effectiveness of therapeutic hypothermia. By creating detailed models and measurements, the lab aims to innovate ways to diagnose and monitor brain injuries in newborns, ultimately leading to better intervention strategies.

Dr. Muriah D. Wheelock's research lab focuses on understanding how early brain development impacts neurological health later in life, particularly in relation to Alzheimer's disease and other neurodegenerative disorders. The lab studies brain functional connectivity in infants and toddlers to explore how early life experiences and conditions, such as low birth weight or trauma, influence brain development and long-term health outcomes. By analyzing brain imaging data and employing advanced techniques, the lab aims to uncover critical patterns that can inform prevention and intervention strategies for childhood development and aging.

Dr. David M. Wilson's lab at UCSF focuses on developing advanced imaging techniques to enhance our understanding and diagnosis of Alzheimer's disease and other conditions. They work on creating new PET imaging tracers that can help visualize changes in brain cells associated with Alzheimer’s, as well as tracers designed to detect bacterial infections more effectively. Their research aims to bridge the gap between innovative tracer synthesis and real-world clinical applications, benefiting patients with neurological and infectious diseases.

Dr. Jakob Asslaender's lab focuses on developing advanced MRI techniques to enhance the accuracy of imaging in clinical settings, particularly for neurological diseases like multiple sclerosis. The research aims to improve the objectivity and comparability of MRI data by refining a specialized imaging model that reduces scan times while boosting the sensitivity and specificity of results. This work is vital for advancing precision medicine and ensuring better diagnosis and treatment planning in neurology.

Dr. Christos Davatzikos leads a lab at the University of Pennsylvania that focuses on using advanced imaging and machine learning techniques to study the brain. The research primarily explores how the brain changes with aging and how these changes relate to conditions like Alzheimer's disease and glioblastoma. The lab aims to improve early diagnosis and treatment strategies for neurodegenerative disorders using large datasets and innovative analytical methods.